Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for MTD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -317.75M
March 31, 2026 -114.33M
December 31, 2025 -192.14M
September 30, 2025 -192.89M
June 30, 2025 -186.00M
March 31, 2025 -184.14M
December 31, 2024 -223.69M
September 30, 2024 -218.90M
June 30, 2024 -234.30M
March 31, 2024 -179.08M
December 31, 2023 -248.97M
September 30, 2023 -245.55M
June 30, 2023 -227.43M
March 31, 2023 -137.64M
December 31, 2022 -285.43M
September 30, 2022 -177.28M
June 30, 2022 -188.84M
March 31, 2022 -64.48M
December 31, 2021 -264.24M
September 30, 2021 -195.69M
June 30, 2021 -177.29M
March 31, 2021 46.68M
December 31, 2020 -286.47M
September 30, 2020 -182.36M
June 30, 2020 -362.36M
Date Value
March 31, 2020 87.28M
December 31, 2019 -95.20M
September 30, 2019 -145.28M
June 30, 2019 -100.69M
March 31, 2019 -136.20M
December 31, 2018 -113.46M
September 30, 2018 -146.05M
June 30, 2018 -20.84M
March 31, 2018 -107.68M
December 31, 2017 -152.28M
September 30, 2017 15.20M
June 30, 2017 -128.52M
March 31, 2017 -53.94M
December 31, 2016 -61.68M
September 30, 2016 18.44M
June 30, 2016 -94.22M
March 31, 2016 -8.465M
December 31, 2015 -133.17M
September 30, 2015 -124.08M
June 30, 2015 -9.536M
March 31, 2015 -40.25M
December 31, 2014 -149.82M
September 30, 2014 -86.23M
June 30, 2014 -89.91M
March 31, 2014 -22.14M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Waters Corp. -124.00M
Agilent Technologies, Inc. 471.00M
Bio-Rad Laboratories, Inc. -27.60M
Danaher Corp. 7.273B
Revvity, Inc. -23.16M